Technological development of structural DNA/RNA-based RNAi systems and their applications

Eun Hye Jeong, Hyejin Kim, Bora Jang, Hyesoo Cho, Jaehee Ryu, Boyeon Kim, Youngkuk Park, Jieun Kim, Jong Bum Lee, Hyukjin Lee

Research output: Contribution to journalReview articlepeer-review

32 Scopus citations


RNA interference (RNAi)-based gene therapy has drawn tremendous attention due to its highly specific gene regulation by selective degradation of any target mRNA. There have been multiple reports regarding the development of various cationic materials for efficient siRNA delivery, however, many studies still suffer from the conventional delivery problems such as suboptimal transfection performance, a lack of tissue specificity, and potential cytotoxicity. Despite the huge therapeutic potential of siRNAs, conventional gene carriers have failed to guarantee successful gene silencing in vivo, thus not warranting clinical trials. The relatively short double-stranded structure of siRNAs has resulted in uncompromising delivery formulations, as well as low transfection efficiency, compared with the conventional nucleic acid drugs such as plasmid DNAs. Recent developments in structural siRNA and RNAi nanotechnology have enabled more refined and reliable in vivo gene silencing with multiple advantages over naked siRNAs. This review focuses on recent progress in the development of structural DNA/RNA-based RNAi systems and their potential therapeutic applications. In addition, an extensive list of prior reports on various RNAi systems is provided and categorized by their distinctive molecular characters.

Original languageEnglish
Pages (from-to)29-43
Number of pages15
JournalAdvanced Drug Delivery Reviews
StatePublished - 2016


  • Nanotechnology
  • RNAi
  • Structural DNA/RNA
  • siRNA


Dive into the research topics of 'Technological development of structural DNA/RNA-based RNAi systems and their applications'. Together they form a unique fingerprint.

Cite this